---
category: news
title: "Kiromic BioPharma Reports First Quarter 2021 Financial Results and Continued Corporate Progress"
excerpt: "Kiromic BioPharma (NASDAQ: KRBP), a pre-clinical stage biotechnology company using its proprietary DIAMOND® artificial intelligence (“A.I.”) platform to improve drug discovery and development with a therapeutic focus on immune-oncology,"
publishedDateTime: 2021-05-14T11:50:00Z
originalUrl: "https://www.morningstar.com/news/business-wire/20210514005463/kiromic-biopharma-reports-first-quarter-2021-financial-results-and-continued-corporate-progress"
webUrl: "https://www.morningstar.com/news/business-wire/20210514005463/kiromic-biopharma-reports-first-quarter-2021-financial-results-and-continued-corporate-progress"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Morningstar, Inc.
  domain: morningstar.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Kiromic BioPharma Reports First Quarter 2021 Financial Results and Continued Corporate Progress"
    excerpt: "Kiromic BioPharma achieved important scientific and operational milestones during the year that we believe have us well positioned for preparing our staff and our facilities for the first in-human dosing in Q3 2021,"
    publishedDateTime: 2021-05-14T20:50:00Z
    webUrl: "https://www.businesswire.com/news/home/20210514005463/en/Kiromic-BioPharma-Reports-First-Quarter-2021-Financial-Results-and-Continued-Corporate-Progress"
    type: article
    provider:
      name: Business Wire
      domain: businesswire.com
    quality: 0

secured: "Kd/5l2UcKyLHKjTO7FGYicqgQdFCMax5y79hwZBYbCe7nDsEz0WuIDrdKzYE6Xy5App6/S4WPanO093Kcfm/3zX/V4HVs571Be3JDMoXX74rm5OnmdHypikRzklLTIwwYlTMRicQDlQTjm7QhJvvU9Tz2UIhYBuC9Om4O+yTvikWuzv3amonfyYJZpWtpLyNWCcQq+kloyZ47IrXNJqp4sByyMvugdzEE1MlzL9hOPvhQ6haVbJIxiX0wuDBGSNejy5g37Rk1FBu/YDLn8kMiLOCm8ldLoOS3DzZej3aMWHD4W/TdCSQdycCusV4+xTkGSdMDSK/ra/10wrglPZVB7A751PE8flDLBBhc0Wg+sA=;ZbrFzzDxqsy/agQOgQ3UNg=="
---

